Eargo faces delisting if it fails to provide Q3 report
US-based hearing aid manufacturer Eargo, which is the center of an investigation concerning potential reimbursement fraud, is now being threatened with delisting by New York stock exchange Nasdaq, as it has yet to file its third quarterly report.
BY MIKKEL AABENHUS HEMMINGSEN, TRANSLATED BY DANIEL PEDERSEN
Hearing aid manufacturer Eargo, which is spearheaded by the Dane Christian Gormsen, is once again in hot water.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Hearing industry challenger applauds Biden's price battle
For subscribers
.jpg&w=384&q=75)
